BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mizwicki MT, Liu G, Fiala M, Magpantay L, Sayre J, Siani A, Mahanian M, Weitzman R, Hayden EY, Rosenthal MJ, Nemere I, Ringman J, Teplow DB. 1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients. J Alzheimers Dis 2013;34:155-70. [PMID: 23186989 DOI: 10.3233/JAD-121735] [Cited by in Crossref: 76] [Cited by in F6Publishing: 46] [Article Influence: 8.4] [Reference Citation Analysis]
Number Citing Articles
1 Schlögl M, Holick MF. Vitamin D and neurocognitive function. Clin Interv Aging 2014;9:559-68. [PMID: 24729696 DOI: 10.2147/CIA.S51785] [Cited by in Crossref: 14] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
2 Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92-101. [PMID: 24899309 DOI: 10.1038/nature13479] [Cited by in Crossref: 1482] [Cited by in F6Publishing: 1393] [Article Influence: 185.3] [Reference Citation Analysis]
3 Li C, Wu X, Liu S, Shen D, Zhu J, Liu K. Role of Resolvins in the Inflammatory Resolution of Neurological Diseases. Front Pharmacol 2020;11:612. [PMID: 32457616 DOI: 10.3389/fphar.2020.00612] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
4 Chamani S, Bianconi V, Tasbandi A, Pirro M, Barreto GE, Jamialahmadi T, Sahebkar A. Resolution of Inflammation in Neurodegenerative Diseases: The Role of Resolvins. Mediators Inflamm 2020;2020:3267172. [PMID: 32308554 DOI: 10.1155/2020/3267172] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
5 Wu H, Khuram Raza H, Li Z, Li Z, Zu J, Xu C, Yang D, Cui G. Correlation between serum 25(OH)D and cognitive impairment in Parkinson's disease. J Clin Neurosci 2022;100:192-5. [PMID: 35489254 DOI: 10.1016/j.jocn.2022.04.015] [Reference Citation Analysis]
6 Decker C, Sadhu S, Fredman G. Pro-Resolving Ligands Orchestrate Phagocytosis. Front Immunol 2021;12:660865. [PMID: 34177900 DOI: 10.3389/fimmu.2021.660865] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhu M, Wang X, Sun L, Schultzberg M, Hjorth E. Can inflammation be resolved in Alzheimer's disease? Ther Adv Neurol Disord 2018;11:1756286418791107. [PMID: 30116300 DOI: 10.1177/1756286418791107] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
8 Snowden SG, Ebshiana AA, Hye A, An Y, Pletnikova O, O'Brien R, Troncoso J, Legido-Quigley C, Thambisetty M. Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study. PLoS Med 2017;14:e1002266. [PMID: 28323825 DOI: 10.1371/journal.pmed.1002266] [Cited by in Crossref: 137] [Cited by in F6Publishing: 125] [Article Influence: 27.4] [Reference Citation Analysis]
9 Chiurchiù V, Leuti A, Maccarrone M. Bioactive Lipids and Chronic Inflammation: Managing the Fire Within. Front Immunol 2018;9:38. [PMID: 29434586 DOI: 10.3389/fimmu.2018.00038] [Cited by in Crossref: 140] [Cited by in F6Publishing: 127] [Article Influence: 35.0] [Reference Citation Analysis]
10 Poisson LM, Suhail H, Singh J, Datta I, Denic A, Labuzek K, Hoda MN, Shankar A, Kumar A, Cerghet M, Elias S, Mohney RP, Rodriguez M, Rattan R, Mangalam AK, Giri S. Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis. J Biol Chem 2015;290:30697-712. [PMID: 26546682 DOI: 10.1074/jbc.M115.679068] [Cited by in Crossref: 39] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
11 Lee JY, Han SH, Park MH, Baek B, Song IS, Choi MK, Takuwa Y, Ryu H, Kim SH, He X, Schuchman EH, Bae JS, Jin HK. Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer's Disease. Nat Commun 2018;9:1479. [PMID: 29662056 DOI: 10.1038/s41467-018-03674-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
12 Joffre C, Dinel AL, Chataigner M, Pallet V, Layé S. n-3 Polyunsaturated Fatty Acids and Their Derivates Reduce Neuroinflammation during Aging. Nutrients 2020;12:E647. [PMID: 32121189 DOI: 10.3390/nu12030647] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
13 Dursun E, Candaş E, Yılmazer S, Gezen-Ak D. Amyloid Beta 1-42 Alters the Expression of miRNAs in Cortical Neurons. J Mol Neurosci 2019;67:181-92. [PMID: 30515701 DOI: 10.1007/s12031-018-1223-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
14 Grimm MOW, Michaelson DM, Hartmann T. Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention. J Lipid Res 2017;58:2083-101. [PMID: 28528321 DOI: 10.1194/jlr.R076331] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
15 Heras-Sandoval D, Pedraza-Chaverri J, Pérez-Rojas JM. Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease. J Neuroinflammation 2016;13:61. [PMID: 26965310 DOI: 10.1186/s12974-016-0525-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 6.8] [Reference Citation Analysis]
16 Almeida L, Everts B. Fa(c)t checking: How fatty acids shape metabolism and function of macrophages and dendritic cells. Eur J Immunol 2021;51:1628-40. [PMID: 33788250 DOI: 10.1002/eji.202048944] [Reference Citation Analysis]
17 Giacobbe J, Benoiton B, Zunszain P, Pariante CM, Borsini A. The Anti-Inflammatory Role of Omega-3 Polyunsaturated Fatty Acids Metabolites in Pre-Clinical Models of Psychiatric, Neurodegenerative, and Neurological Disorders. Front Psychiatry 2020;11:122. [PMID: 32180741 DOI: 10.3389/fpsyt.2020.00122] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
18 Garcia-Gil M, Pierucci F, Vestri A, Meacci E. Crosstalk between sphingolipids and vitamin D3: potential role in the nervous system. Br J Pharmacol 2017;174:605-27. [PMID: 28127747 DOI: 10.1111/bph.13726] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
19 Wang L, Ying J, Fan P, Weamer EA, DeMichele-Sweet MAA, Lopez OL, Kofler JK, Sweet RA. Effects of Vitamin D Use on Outcomes of Psychotic Symptoms in Alzheimer Disease Patients. Am J Geriatr Psychiatry 2019;27:908-17. [PMID: 31126722 DOI: 10.1016/j.jagp.2019.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
20 Overman MJ, Pendleton N, O'Neill TW, Bartfai G, Casanueva FF, Finn JD, Forti G, Rastrelli G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean MEJ, Punab M, Lee DM, Correa ES, Ahern T, Verschueren SMP, Antonio L, Gielen E, Rutter MK, Vanderschueren D, Wu FCW, Tournoy J; EMAS Study Group. Evaluation of cognitive subdomains, 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D in the European Male Ageing Study. Eur J Nutr 2017;56:2093-103. [PMID: 27370643 DOI: 10.1007/s00394-016-1247-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
21 Famenini S, Rigali EA, Olivera-Perez HM, Dang J, Chang MT, Halder R, Rao RV, Pellegrini M, Porter V, Bredesen D, Fiala M. Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementation. FASEB J 2017;31:148-60. [PMID: 27677546 DOI: 10.1096/fj.201600677RR] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
22 Gallo CG, Fiorino S, Posabella G, Antonacci D, Tropeano A, Pausini E, Pausini C, Guarniero T, Hong W, Giampieri E, Corazza I, Loiacono R, Loggi E, de Biase D, Zippi M, Lari F, Zancanaro M. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection. Prostaglandins Other Lipid Mediat 2022;:106619. [PMID: 35032665 DOI: 10.1016/j.prostaglandins.2022.106619] [Reference Citation Analysis]
23 Uthaiah CA, Beeraka NM, Rajalakshmi R, Ramya CM, Madhunapantula SV. Role of Neural Stem Cells and Vitamin D Receptor (VDR)-Mediated Cellular Signaling in the Mitigation of Neurological Diseases. Mol Neurobiol 2022. [PMID: 35476289 DOI: 10.1007/s12035-022-02837-z] [Reference Citation Analysis]
24 Serhan CN, Chiang N, Dalli J. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution. Semin Immunol. 2015;27:200-215. [PMID: 25857211 DOI: 10.1016/j.smim.2015.03.004] [Cited by in Crossref: 310] [Cited by in F6Publishing: 283] [Article Influence: 44.3] [Reference Citation Analysis]
25 Schaller MS, Zahner GJ, Gasper WJ, Harris WS, Conte MS, Hills NK, Grenon SM. Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements. J Clin Lipidol 2017;11:1289-95. [PMID: 28778393 DOI: 10.1016/j.jacl.2017.06.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
26 Serhan CN, Chiang N. Resolution phase lipid mediators of inflammation: agonists of resolution. Curr Opin Pharmacol 2013;13:632-40. [PMID: 23747022 DOI: 10.1016/j.coph.2013.05.012] [Cited by in Crossref: 201] [Cited by in F6Publishing: 190] [Article Influence: 22.3] [Reference Citation Analysis]
27 Fiala M, Restrepo L, Pellegrini M. Immunotherapy of Mild Cognitive Impairment by ω-3 Supplementation: Why Are Amyloid-β Antibodies and ω-3 Not Working in Clinical Trials? J Alzheimers Dis 2018;62:1013-22. [PMID: 29103035 DOI: 10.3233/JAD-170579] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
28 Zhang D, Cao Y, Zuo Y, Wang Z, Mi X, Tang W. Integrated bioinformatics analysis reveals novel hub genes closely associated with pathological mechanisms of immunoglobulin A nephropathy. Exp Ther Med 2019;18:1235-45. [PMID: 31316619 DOI: 10.3892/etm.2019.7686] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
29 Zhu M, Wang X, Hjorth E, Colas RA, Schroeder L, Granholm AC, Serhan CN, Schultzberg M. Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis. Mol Neurobiol 2016;53:2733-49. [PMID: 26650044 DOI: 10.1007/s12035-015-9544-0] [Cited by in Crossref: 87] [Cited by in F6Publishing: 87] [Article Influence: 12.4] [Reference Citation Analysis]
30 Serhan CN, Chiang N, Dalli J, Levy BD. Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol. 2015;7:a016311. [PMID: 25359497 DOI: 10.1101/cshperspect.a016311] [Cited by in Crossref: 218] [Cited by in F6Publishing: 208] [Article Influence: 27.3] [Reference Citation Analysis]
31 Fullard ME, Duda JE. A Review of the Relationship Between Vitamin D and Parkinson Disease Symptoms. Front Neurol 2020;11:454. [PMID: 32536905 DOI: 10.3389/fneur.2020.00454] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
32 Bredesen DE, John V. Next generation therapeutics for Alzheimer's disease. EMBO Mol Med 2013;5:795-8. [PMID: 23703924 DOI: 10.1002/emmm.201202307] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
33 de Wilde MC, Vellas B, Girault E, Yavuz AC, Sijben JW. Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses. Alzheimers Dement (N Y) 2017;3:416-31. [PMID: 29067348 DOI: 10.1016/j.trci.2017.06.002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 11.8] [Reference Citation Analysis]
34 Keeney JTR, Förster S, Sultana R, Brewer LD, Latimer CS, Cai J, Klein JB, Porter NM, Butterfield DA. Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: implications for low vitamin D-dependent age-related cognitive decline. Free Radic Biol Med 2013;65:324-34. [PMID: 23872023 DOI: 10.1016/j.freeradbiomed.2013.07.019] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
35 Duvall MG, Levy BD. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur J Pharmacol 2016;785:144-55. [PMID: 26546247 DOI: 10.1016/j.ejphar.2015.11.001] [Cited by in Crossref: 106] [Cited by in F6Publishing: 104] [Article Influence: 15.1] [Reference Citation Analysis]
36 Chatterjee A, Sharma A, Chen M, Toy R, Mottola G, Conte MS. The pro-resolving lipid mediator maresin 1 (MaR1) attenuates inflammatory signaling pathways in vascular smooth muscle and endothelial cells. PLoS One 2014;9:e113480. [PMID: 25409514 DOI: 10.1371/journal.pone.0113480] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 6.4] [Reference Citation Analysis]
37 Lorente-Cebrián S, Costa AG, Navas-Carretero S, Zabala M, Laiglesia LM, Martínez JA, Moreno-Aliaga MJ. An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases. J Physiol Biochem 2015;71:341-9. [PMID: 25752887 DOI: 10.1007/s13105-015-0395-y] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 8.1] [Reference Citation Analysis]
38 Fiala M, Kooij G, Wagner K, Hammock B, Pellegrini M. Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids. FASEB J 2017;31:3229-39. [PMID: 28420693 DOI: 10.1096/fj.201700065R] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
39 Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol 2016;16:51-67. [PMID: 26688348 DOI: 10.1038/nri.2015.4] [Cited by in Crossref: 250] [Cited by in F6Publishing: 239] [Article Influence: 35.7] [Reference Citation Analysis]
40 Wang X, Hjorth E, Vedin I, Eriksdotter M, Freund-Levi Y, Wahlund LO, Cederholm T, Palmblad J, Schultzberg M. Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study. J Lipid Res 2015;56:674-81. [PMID: 25616438 DOI: 10.1194/jlr.P055418] [Cited by in Crossref: 44] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
41 de Wit NM, Mol K, Rodríguez-Lorenzo S, de Vries HE, Kooij G. The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer's Disease. Front Immunol 2020;11:620348. [PMID: 33633739 DOI: 10.3389/fimmu.2020.620348] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Joffre C, Rey C, Layé S. N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation. Front Pharmacol 2019;10:1022. [PMID: 31607902 DOI: 10.3389/fphar.2019.01022] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 12.7] [Reference Citation Analysis]
43 Miyazawa K, Fukunaga H, Tatewaki Y, Takano Y, Yamamoto S, Mutoh T, Taki Y. Alzheimer's Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment? Int J Mol Sci 2020;21:E5783. [PMID: 32806612 DOI: 10.3390/ijms21165783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
44 Ponce J, Ulu A, Hanson C, Cameron-smith E, Bertoni J, Wuebker J, Fisher A, Siu K, Marmelat V, Adamec J, Bhatti D. Role of Specialized Pro-resolving Mediators in Reducing Neuroinflammation in Neurodegenerative Disorders. Front Aging Neurosci 2022;14:780811. [DOI: 10.3389/fnagi.2022.780811] [Reference Citation Analysis]
45 Olivera-Perez HM, Lam L, Dang J, Jiang W, Rodriguez F, Rigali E, Weitzman S, Porter V, Rubbi L, Morselli M, Pellegrini M, Fiala M. Omega-3 fatty acids increase the unfolded protein response and improve amyloid-β phagocytosis by macrophages of patients with mild cognitive impairment. FASEB J 2017;31:4359-69. [PMID: 28634213 DOI: 10.1096/fj.201700290R] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
46 Landel V, Annweiler C, Millet P, Morello M, Féron F. Vitamin D, Cognition and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails. J Alzheimers Dis 2016;53:419-44. [PMID: 27176073 DOI: 10.3233/JAD-150943] [Cited by in Crossref: 84] [Cited by in F6Publishing: 31] [Article Influence: 21.0] [Reference Citation Analysis]
47 Cisbani G, Rivest S. Targeting innate immunity to protect and cure Alzheimer's disease: opportunities and pitfalls. Mol Psychiatry 2021. [PMID: 33854189 DOI: 10.1038/s41380-021-01083-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
48 Jiang X, Xu Z, Du Y, Chen H. Bioinformatics analysis reveals novel hub gene pathways associated with IgA nephropathy. Eur J Med Res 2020;25:40. [PMID: 32894197 DOI: 10.1186/s40001-020-00441-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Hohsfield LA, Humpel C. Migration of blood cells to β-amyloid plaques in Alzheimer's disease. Exp Gerontol 2015;65:8-15. [PMID: 25752742 DOI: 10.1016/j.exger.2015.03.002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
50 Siqueira LD, Celes APM, Santos HD, Ferreira ST. A Specialized Nutritional Formulation Prevents Hippocampal Glial Activation and Memory Impairment Induced by Amyloid-β Oligomers in Mice. J Alzheimers Dis 2021;83:1113-24. [PMID: 34397411 DOI: 10.3233/JAD-210139] [Reference Citation Analysis]
51 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
52 Bredesen DE. Metabolic profiling distinguishes three subtypes of Alzheimer's disease. Aging (Albany NY) 2015;7:595-600. [PMID: 26343025 DOI: 10.18632/aging.100801] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
53 Landel V, Millet P, Baranger K, Loriod B, Féron F. Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's disease. Mol Neurodegener 2016;11:22. [PMID: 26932723 DOI: 10.1186/s13024-016-0087-2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]